Expression of glycolipid blood group antigens in single human kidneys: Change in antigen expression of rejected ABO incompatible kidney grafts. Total neutral glycolipid fractions were separated into molecular species on thin-layer chromatography plates and detected by immunostaining with monoclonal anti-blood group antibodies. Blood group A antigens based on type 1, 2, 3 and 4 carbohydrate core saccharides were present in kidneys of A1 and A1B individuals. Blood group A2 individuals expressed only small amounts of A antigen compared to A1 individuals especially of the type 3 and 4 compounds. Kidneys from non-secretor individuals contained less A antigen compared to secretor individuals, and in both groups a variation in the antigen expression between single individuals was noted. Blood group A type 2 and 3 (which is an extension of A type 2) antigens were present both as basic 6 and 9 sugar structures as well as extended saccharide chains migrating in the 8 to II sugar interval. In contrast, the type 1 chain based A and Lewis antigens were only present as their basic 5 to 7 sugar chains, and no elongated structures were found. Four cases of A2 kidneys initially transplanted into 0 recipients and removed after 5, 12, 21 days and 4 years, respectively, were also analyzed. Two of these kidneys, originating from the same donor, showed a difference in A antigen expression. The kidney functioning for four years (lost due to chronic rejection) completely lacked X antigen with five sugar residues (present in all other individuals) and contained a large amount of A antigens. This shows that the expression of antigens in an incompatible transplated organ can be changed post-transplantation, and that the organ can function even if large amounts of incompatible antigens are present.
tissue and cell specific distribution [8] and are present on virtually every cell in the body. Phylogenetic studies have shown that these antigens appear earlier in evolution in ectodermal or endodermal tissues and cells compared to mesenchymal hematopoietic cells [5] , Therefore the term "histo-blood group" antigens have been proposed for these carbohydrate antigens [6] .
The ABH and related carbohydrate antigens are located on the cell surface and are proposed to take part in cell-cell communication phenomena [10] . They are also targets for antibodies, which was shown in studies of ABO incompatible transfusion [11] and organ transplantations [12] where both antigen and individual specific antibody responses were produced in the recipients challenged with incompatible blood group A antigen. Transplantation of kidneys involving major ABO incompatibilities have been performed with good results using an aggressive immunosupression regimen including spleenectomy [13, 14] , and kidneys from A2 donors can be transplanted to 0 recipients using standard immunosuppression [15] . We have described a difference in the expression of A antigens in human kidney from single individuals using a monoclonal anti-A antibody reacting with all A determinants [15, 16] . In this paper the expression of structurally different glycolipid based A, Lewis and X/Y antigens in several human kidneys from single individuals are analyzed by use of a panel of specific monoclonal antibodies. In addition, blood group A2 kidneys transplanted into 0 recipients and later removed after various time periods were also analyzed.
Methods
Kidney specimens The kidney specimens were obtained from the transplantation unit, Sahlgren's Hospital. The kidneys were discarded for lack of suitable recipients or for technical reasons. The kidneys were perfused with kidney storage solution, kept cool and sterile. Blood group typing of the donors' erythrocytes was performed at the blood bank by standard procedures. Secretor No A subtyping performed Kidney transplanted to a blood group 0 recipient and removed on day 21 [15] Kidney transplanted to a blood group 0 recipient and removed on day 5 due to irreversible vascular rejection, case 11:2 in [12] Same donor as case 13 [12] status was deduced from the Lewis typing. In some cases blood group A2 kidneys initially transplanted to blood group 0 recipients and removed after different time periods were obtained and analyzed. The blood group types and relevant clinical data for each kidney specimen are listed in Table 1 .
Glycolipid preparation Total neutral glycosphingolipid fractions were prepared from the lyophilized kidney tissues as described in detail [171. The average amount of total neutral glycolipid fractions isolated from each non-transplanted kidney was 118 mg (range 61 to 195 mg) corresponding to 5.5 mg per g dry tissue weight (range 4.7 to 7.9 mg). The values for the transplanted and rejected kidneys were 272 mg (188 to 334 mg) corresponding to 5.6 mg per g dry tissue weight (3.7 to 9.4 mg).
Thin-layer chromatography and immunostaining of the plates Thin-layer chromatography was performed on HPTLC-aluminium-plates (Merck, Darmstadt, Germany) and developed in chloroform: methanol: water, 60: 35:8 (vol :vol:vol) . Detection was accomplished by a chemical reagent, anisaldehyde [171 or by autoradiography after incubating the plate with monoclonal anti-blood group antibodies, followed by '251-labeled secondary antibody using a modification of the method by Magnani et al [8, 12, 18] .
Monoclonal antibodies and glycolipid reference samples The mouse monoclonal antibodies, reference glycolipid samples and glycolipid short hand nomenclature used are described in Tables 2 and 3 , respectively.
Results
The total non-acid glycolipid pattern of the human kidneys were very similar when the plates were stained with a chemical reagent [9, 15, 16] (not shown). The major components present had 1 to 4 sugar residues and small amounts of 5 sugar components are also seen [9, 15, 16] . The amount of complex blood group type glycolipids was estimated to about 1% of the total glycolipid fraction [9] , and were not seen on the plate using a chemical reagent but were detected by immunostaining the plates with antibodies [15, 16] , as shown in Figure 1 . The staining of glycolipid antigens on thin-layer plates by biological reagents such as monoclonal antibodies, lectins, toxins and bacteria/virus is a qualitative and a "semiquantitative" technique for antigen identification [11, 12, 29, 30] . Therefore, the results were presented as autoradiograms ( Fig. 1) and not as numeric figures. The anti-A antibody used in Figure 1A recognized the terminal A trisaccharide and reacted with all structural variants of A antigens [16] . This antibody revealed a very complex pattern of A structures in the kidneys of A1 individuals (lanes 1 to 9) while the A2 individuals stained very faintly (lane 10) or not at all (lane 11). In addition to the components migrating as the reference compounds with 6 to 9 sugar residues, several slow moving components with about 10 to 12 sugar residues were seen in some of the A1 individuals. The A2 kidneys which had been transplanted into 0 recipients were all negative or faintly stained (lanes 12 to 14), except for one case (lane 15). The antibodies AH-21 and HH-4 are specific for A monofucosyl structures based on type 1 and 2 core chain structures, respectively. The AH-21 antibody stained a 6 sugar component present in all A1 kidneys and in some of the A2 kidneys (Fig. 1B) while the HH-4 antibody stained components in the 8-9 sugar region in some of the A1 kidneys in addition to the major staining present in the 6 sugar region of all A1 individuals (Fig. lC) . The A2 kidneys transplanted into 0 recipients were all stained in various degrees with the A type 2 antibody (Fig. 1C) . The TH-1 antibody, specific for A type 3 chain compounds (Fig. 1D ) reacted with a 9 sugar structure present in the A1 kidneys but was absent in the A2 kidneys except for a very faint staining in one case (lane 10). The type 3 chain compound in the kidneys migrated just below the A-9-3 reference compound from human erythrocytes. This difference 
No Lewis typing performed GalNAcal-3(Fucal-2)Gall3l-3GlcNAcI3l-3GalI3l-4Glcf3l-lCer Human meconium [23] A-6-2
GalNAcal-3(Fucal-2)Gal/3l-4GlcNAc/31-3Gall-4Glcfll-lCer Dog small intestine [24] A-7-l GalNAcal-3(Fucal-2)Gall-3(Fuca1-4)GlcNAcl-3Gal/31-4Glc/3l-ICer Human meconium [23] A-7-4
GalNAcal-3(Fucal-2)Galj3l-3GaINAc/3l-3Galal-4Gal/3l-4Glc/31-lCer Human kidney [25] A-9-3
Human erythrocytes [4, 26] Ga1131-4GlcI3l-lCer
Lea5
Gal/31-3(Fucal-4)GIcNAcI3I-3Gal/3l-4Glc/3l-ICer
Human small intestine Leb6
Fucal-2GalI3l-3(Fucal-4)GlcNAc/31-3Galf3l-4GlcI3l-ICer Human small intestine [27] [7]
X-5 Galf3l-4(Fucal-3)GlcNAc/31-3Gal/3l-4Glc/3l-lCer Dog small intestine [28] Y-6 Fucal-2Gal/3l-4(Fucal-3)GlcNAcj3l-3Galf3l-4Glc/31-lCer Dog small intestine [28] a For blood group glycolipids, the letter indicates blood group determinant, the first numeral the number of sugar residues, and the second numeral the type of carbohydrate chain in mobility was most likely due to a more hydroxylated ceramide [31] than to a different carbohydrate structure. The HH-5 antibody recognizing both type 3 and 4 chain A compounds reacted with several bands in the A1 kidneys of which the A-7-4 and A-9-3 were the dominating compounds (Fig. 1E ). For the A2 kidneys a weaker and more variable staining was seen. The relatively weak staining of A type 3 and 4 compounds in Figure   lA compared to Figure IE was due to a weaker reactivity of these antigens with general anti-A antibodies recognizing the terminal A trisaccharide [20] . Blood group A difucosyl type I chain (ALeb) compounds with 7 sugar residues were present in all A1 kidneys (Fig. iF) but the staining of A1Le(a+b-) individuals was weaker (lanes 6 and 7) and the A2 kidneys (lanes 10 and 11) were negative while the transplanted kidneys (lanes 12 to 15) showed a variable staining.
The anti-B antibody reacted only with the blood group AB kidneys (cases 8 and 9) as expected (not shown). The staining was present only in the 6 sugar region of the chromatogram, in contrast to blood group B kidneys obtained at autopsy [32] which also contained blood group B compounds in the 7-8 sugar interval, most probably originating from erythi-ocytes trapped in the organ. The antiLea antibody stained a five sugar component present in variable amounts in all A1 kidneys and in some of the transplanted A2 kidneys (Fig. 1G) . Leb antigens with 6 sugar residues were present in a similar manner (Fig.   lH) . In some cases (for example, 7) Leb antigens were found in a serological Leb negative individual, a phenomenon reported before for human meconium [33] and small intestine [8] .
The X antigens are the type 2 chain isomers of the Lea antigens, and these were detected by the SH-1 antibody reacting with the terminal X trisaccharide determinant. This antibody reacted with a 5 sugar component present in all kidneys (Fig. LI) except case 15. The X-5 glycolipid has been structurally identified as one of two components present in the 5 sugar band detected by the chemical staining of the plates [9, 321. In the transplanted kidneys several bands were stained (lanes 12 to 15) migrating below the 5 sugar component. These are probably elongated repetitive X structures originating from white blood cells trapped in the rejected organs, since granulocytes have been shown to contain large amounts of these components [34] . A similar distribution for the corresponding Y antigens (type 2 chain isomers of Leb) was also found (Fig. U) with only trace amounts of a 6 sugar component in some of the nontransplanted kidneys, while several slow moving bands were seen in the transplanted cases (lanes 12 to 15).
Discussion
The kidneys analyzed are a unique human tissue collection obtained during a ten year period. Since the kidneys were Tables I and 3 , respectively. The kidney fractions were subgrouped into blood group A1 (left column, lanes I to 9) and A2 (right column, lanes 10 to 15), of which cases 12 to 15 were A2 kidneys transplanted to blood group 0 individuals and removed after various time periods (Table I ). The monoclonal antibodies used were: A, A581; B, AH-21; C, HH-4; D, TH-I, E, HH-5; F, HH-3; G; XALA; H, 9ALB; I, SH-l; and J, AH-6. The specificity of the monoclonal antibodies is given in Table 2 . The amount of glycolipid substance applied was about 40 jsg of the kidney fractions, 20 jig of the erythrocyte fraction and 0.2 jig of each pure reference compound. The chemical staining of plates (not shown) revealed no differences between the individuals [15, 16] , since the blood group components make up only about 1% of the glycolipis and are not detected by chemical staining [9] . Arrows indicate sample origin.
E Atype3and4
A-7-1 1 2 3 4 5 6 7 8 9A-7-1 E A-7-1 1 10 11 12 13 14 15 intended for transplantation, they were perfused with salt solution, removing plasma and blood cells, and thereafter stored sterile at low temperature. For most of the cases an extended blood group typing (A1/A2 and Lewis) of the donor erythrocytes was performed, but in some of the cases this was not possible due to lack of blood samples. From the Lewis erythrocyte phenotype, the secretor status was be concluded
where Le(a+b-) individuals are regarded as non-secretors and Le(a-b+) as secretors.
The expression of A antigens in the kidneys is very complex with both quantitative and qualitative differences between the individuals. Comparing the A1, (Fig. lÀ through F, lanes I to 9) and A2 (lanes 10 to 11) kidneys, the A1 kidneys contain larger amounts and have a more complex expression of the A antigens than the A2 kidneys. However, within the A1 group considerable differences are seen of which some, but not all, can be related to the secretor (lanes 1 to 5) and non-secretor (lanes 6 to 7) status. The A type 2 and A type 3 (which is an extension of type 2; Table 3 ) antigens are present both as the basic A-6-2 and A-9-3 structures and with extended saccharide chains migrating in the 8 to 11 sugar interval ( Fig. lC and E) . In contrast, the type 1 chain compounds are only present as their basic structures with five (Lea5), six (A-6-1, Le'-6) and seven (A-7-1) sugar residues. The only extended type 1 chain core saccharide identified so far in human tissues is a repetitive Lea structure with eight sugar residues found in human meconium [35] and small intestine [36] (Holgersson J, Jovall p-A, Karisson K-A, Breimer ME, unpublished observations). A blood group A octaglycosylceramide with a repetitive type 1 chain core saccharide has been found in rat small intestine [37] . For the type 2 chain antigens X and Y, only 5 and 6 sugar compounds, respectively, were identified in the non-transplanted kidneys ( Fig. 11 and J, lanes 1 to 11) but using another anti-X-antibody a 7 sugar component was seen in some of the cases analyzed at that time (38] .
Immunohistochemical studies have shown that the ABH, Lewis and related antigens are specifically distributed in the human kidney. The ABH antigens in the vascular epithelium and the X antigens in the proximal convoluted tubules and descending limb of the loop of Henle are expressed independent of the secretor gene, while the ABH and Lea/Leb antigens in the distal tubules and collecting tubules are secretor dependent [39] [40] [41] . The expression of different blood group antigens in certain tissues and cells has also been correlated to the embryological origin of the tissues [5] . Blood group glycolipids are also known to have a tissue and cell specific distribution [7] [8] [9] and a correlation between the number of hydroxyl groups in the ceramide part and the distribution in different cells has been documented [7, 8, 42] . From the thin-layer mobility and mass spectrometry analysis [9] (Holgersson, J, Jovall p-A, Karlsson K-A, Breimer ME, unpublished observations) the A type 2 chain structures contain less hydroxylated ceramides compared to the type 3 chain structure. This may indicate a different cellular distribution of these compounds, that is, type 2 chain compound in the vascular endothelium and type 3 structures in the distal and collecting tubules. This also fits with the secretor dependent expression of A antigens in the distal and collecting tubules since the amount of A type 3 chain structures are low in non-secretors ( Fig. lD and E, lanes 6 and 7) .
From the results presented here, it can be concluded that the expression of the structurally different A antigens in the human kidney cannot be established from routine blood group typing of the donor erythrocytes, which is the major donor/recipient selection criterion in organ transplantation. The possibility to cross the ABO barriers in kidney transplantation has been shown both by using immunologic modifications of the recipients [13, 14] and using standard immunosuppression regimens [15] . In certain situations, the possibility to cross the ABO barriers may be necessary, and in these cases a more detailed knowledge of the antigen expression in the organ to be transplanted would be of benefit to select a "low antigenic" organ, such as cases 6, 10 and 11 in Figure 1 . The use of a panel of monoclonal anti-blood group antibodies for serological tests or immunohistological studies of an organ biopsy may be the solution for this problem.
An interesting finding is the difference in blood group glycolipid antigen expression in the two blood group A2 kidneys obtained from the same donor and transplanted into two different blood group 0 recipients (cases 13 and 14 in Fig. 1 corresponding to cases 11:1 and 11:2 in ref. 11). Kidney number 13 was removed on day 5 post-transplantation and case 14 on day 12. Kidney 13 was probably not circulated for more than one to two days. Several reasons for the low amounts of A antigens present in case 14 seem possible. Destruction of the antigens by the immune system would result in less antigen expression in the kidney lost after two weeks compared to the one removed after five days. Another possibility would be an influence on the expression by cytokines, for instance gamma interferon, which has been shown under experimental conditions to reduce the expression of neutral glycospingolipids, like globoside, on endothelial cell surfaces [43] . Still another possibility could be the presence of glycosyltransferase inhibitors of an antibody nature being produced in the recipient, influencing the activity of the A-transferase and thus reducing the A antigen expression. Such glycosyltransferase inhibitors have been found in ABO-incompatible bone marrow transplantations [44, 45] , in liver transplantation [46] and in renal transplantation [47] . The sera of patients 13 and 14 obtained four to five weeks after transplantation were investigated for inhibitory activity against A-glycosyltransferase, but no such inhibitor was found (cases 9 and 10 in ref. probably originates from white blood cells in the rejected organs since complex X glycolipid structures are major components in human granulocytes [34] . The origin of the extended Y antigens present in the transplanted kidneys (Fig. 1J , lanes 12 to 15) may be explained in a similar way, but to our knowledge Y antigens have so far not been found in plasma or the various blood cell components. The complete absence of the X-5 compound in the A2 kidney transplanted into an 0 recipient which functioned for four years ( Fig. 1!, lane 15) is of particular interest. Since the X-5 antigen is present in all the non-transplanted kidneys (cases I to II) it originates from the kidney tissue itself. Immunofluorescence studies have shown that the X antigen determinant is restricted to the proximal convoluted tubules and some single granulocytes present in the interstitial compartment [48] . The absence of the X-5 antigen in case 15 may be due to either lack of the antigen before transplantation or a change in the expression occurring post-transplantation as discussed above. Several distinctly different a-3-fucosyltransferase activities have been found in human tissues [5, 49, 50] . No individual lacking the myeloid type of enzyme has been described so far, and only 11 individuals lacking the plasma enzyme have been identified and all were found to be Lewis negative, Le(a-b-) [48, 49] . The low frequency of individuals lacking the a-3-fucosyltransferase, and the fact that the kidney of case 15 contains ALeb, Lea and Leb antigens (Fig. iF, G and H) makes it unlikely that the X-5 antigen was absent in the kidney prior to transplantation. If the absence of X-5 antigens is caused by a lack of enzyme activity, this is most probably due to a lack of the al-3 fucosyltransferase since the presence of A-6-2 compounds (Fig. 1C, lane 15) shows that elongation of the type 2 chain precursor (neolactotetra) is possible. However, it was not possible to test for this since no fresh tissue from that case was available. The other A2 kidneys transplanted into 0 recipients (cases 12 to 14) all contain the X-5 compound, suggesting that the disappearance of this component occurred later in the post-transplantation period.
The problem with hyperacute rejection of allografts caused by anti-ABH or anti-HLA class I antibodies has been overcome by removing the offending antibodies prior to the transplantation, and thereafter maintaining antibody depletion for a finite period [13, 51] . After this period the engrafted organ would continue to function despite the return of the antidonor antibodies and the presence of an intact complement system. This phenomenon has recently been referred to as "accomodation" [52, 53] . In our study, case 15 may be an example of this phenomenon. This blood group A2 kidney transplanted into an o recipient functioned for four years and was lost due to chronic rejection. The removed kidney contained large amounts of blood group A antigens (Fig. 1A to C, and E, lane 15) . At the time of removal of this ABO incompatible kidney, the recipient anti-A agglutinin titer against A1 erythrocytes was 1:16 and the indirect antiglobulin titer 1:32. This shows that "accomodation" can occur also when the incompatible antigens are present in the organ.
